GlassScriptPrepare for your visit
Daniel P Giangrasso
Physical Medicine & Rehabilitation · New York, NY · NPI 1144680349
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$13,590.40
in general payments reported to CMS, 2019-2025 · $987 in 2025
The $987 reported for 2025 was more than what 87% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
Who reported paying
General payments only, top 6 by amount.
- Nevro Corp. $5,432.54
- Boston Scientific Corporation $3,445.95
- Scilex Pharmaceuticals INC. $1,529.76
- Abbott Laboratories $1,100.21
- Medtronic, INC. $545.29
- Si-Bone, INC. $530.42
Drugs and devices associated with these payments
Ztlido Senza Intellis Adaptivestim General - Pain Management Wavewriter Alpha Prime 16 Nimbus Prestige LP Cervical Disc System Botox Eterna Qulipta Elyxyb - Celecoxib
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Daniel Giangrasso listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/7221029/daniel-p-giangrasso